Decision-making cognition in neurodegenerative diseases
- PMID: 21045795
- DOI: 10.1038/nrneurol.2010.148
Decision-making cognition in neurodegenerative diseases
Abstract
A large proportion of human social neuroscience research has focused on the issue of decision-making. Impaired decision-making is a symptomatic feature of a number of neurodegenerative diseases, but the nature of these decision-making deficits depends on the particular disease. Thus, examining the qualitative differences in decision-making impairments associated with different neurodegenerative diseases could provide valuable information regarding the underlying neural basis of decision-making. Nevertheless, few comparative reports of decision-making across patient groups exist. In this Review, we examine the neuroanatomical substrates of decision-making in relation to the neuropathological changes that occur in Alzheimer disease, frontotemporal dementia, Parkinson disease and Huntington disease. We then examine the main findings from studies of decision-making in these neurodegenerative diseases. Finally, we suggest a number of recommendations that future studies could adopt to aid our understanding of decision-making cognition.
Similar articles
-
Neuropsychology of cortical versus subcortical dementia syndromes.Semin Neurol. 2007 Feb;27(1):7-21. doi: 10.1055/s-2006-956751. Semin Neurol. 2007. PMID: 17226737 Review.
-
Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders.Parkinsonism Relat Disord. 2019 Apr;61:77-81. doi: 10.1016/j.parkreldis.2018.11.022. Epub 2018 Nov 26. Parkinsonism Relat Disord. 2019. PMID: 30514650
-
The concept of subcortical dementia.Am J Psychiatry. 1985 Nov;142(11):1312-7. doi: 10.1176/ajp.142.11.1312. Am J Psychiatry. 1985. PMID: 2932922 Review.
-
Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment.Neurology. 2005 Aug 9;65(3):483-5. doi: 10.1212/01.wnl.0000171346.02965.80. Neurology. 2005. PMID: 16087924
-
Neuroendocrine Disturbances in Neurodegenerative Disorders: A Scoping Review.Psychosomatics. 2020 Mar-Apr;61(2):105-115. doi: 10.1016/j.psym.2019.11.002. Epub 2019 Nov 15. Psychosomatics. 2020. PMID: 31918850 Review.
Cited by
-
Risk-taking and pathological gambling behavior in Huntington's disease.Front Behav Neurosci. 2014 Apr 2;8:103. doi: 10.3389/fnbeh.2014.00103. eCollection 2014. Front Behav Neurosci. 2014. PMID: 24765067 Free PMC article. Review.
-
Decision and dopaminergic system: an ERPs study of Iowa gambling task in Parkinson's disease.Front Psychol. 2014 Jul 3;5:684. doi: 10.3389/fpsyg.2014.00684. eCollection 2014. Front Psychol. 2014. PMID: 25071654 Free PMC article.
-
Decision Making under Risk in Patients Suffering from Schizophrenia or Depression.Brain Sci. 2021 Sep 7;11(9):1178. doi: 10.3390/brainsci11091178. Brain Sci. 2021. PMID: 34573199 Free PMC article.
-
Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: a case report.Front Behav Neurosci. 2013 Jul 29;7:95. doi: 10.3389/fnbeh.2013.00095. eCollection 2013. Front Behav Neurosci. 2013. PMID: 23908610 Free PMC article.
-
Insight into differing decision-making strategies that underlie cognitively effort-based decision making using computational modeling in rats.Psychopharmacology (Berl). 2024 May;241(5):947-962. doi: 10.1007/s00213-023-06521-5. Epub 2024 Jan 3. Psychopharmacology (Berl). 2024. PMID: 38172238
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
